Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Contents:; Defining health literacy -- Developments and new directions in health literacy research -- Developments and new directions in health literacy theory -- Health literacy and vulnerable populations -- Health literacy leadership -- Developments and new directions in disciplines similar to he…
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
Contents:; Overview of evidence-based practice / Mary D. Bondmass -- General searching : finding research reports / Ulrike Dieterle and Christopher Hooper-Lane -- Research and the mandate for evidence-based practice, quality, and patient safety / Kathleen R. Stevens -- Establishing and sustaining a…
c.1 BC Cancer Agency VAN Library | Available |
Table of Contents:; I BASIC PRINCIPLES AND CONSIDERATIONS OF RATIONAL CHEMOTHERAPY AND MOLECULAR TARGETED THERAPY -- BIOLOGIC AND PHARMACOLOGIC BASIS OF CANCER CHEMOTHERAPY --BIOLOGIC BASIS OF MOLECULAR TARGETED THERAPY -- PRINCIPLES OF CANCER IMMUNOTHERAPY -- SYSTEMATIC ASSESSMENT OF THE PATIENT W…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
Table of contents:; History of Cancer Immunotherapy -- Section I: Basic Principles of Tumor Immunology -- Section II: Cancer Immunotherapy Targets and Classes -- Section III: Immune Function in Cancer Patients -- Section IV: Disease-Specific Treatments and Outcomes -- Section V: Regulatory Aspects …